Valion Bio, Inc. (VBIO) Free cash flow 2022–2025
Valion Bio, Inc. (VBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.0MFY2025 · since FY2022: -$8.9M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | -22.9% |
| FY2024 | -$5.7M | +33.7% |
| FY2023 | -$8.6M | +3.4% |
| FY2022 | -$8.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net incomeVBIO Net marginVBIO Gross profitVBIO Gross marginVBIO Operating incomeVBIO Operating marginVBIO Operating cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →